DocGo Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
DocGo Inc. (DCGO) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-17
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 506.82K shares, a 67.64% decline from fiscal 2023.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 1.57M shares, a 71.23% decline from fiscal 2022.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 5.44M shares, a 0.94% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | 0.00 shares 10-Q · filed 2026-08-17 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-17 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-11 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-11 | 0.00 shares derived: sum of 3 quarters · filed 2026-05-11 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-16 | 0.00 shares derived: sum of 3 quarters · filed 2026-08-17 | 0.00 shares 10-K · filed 2026-03-16 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | 0.00 shares derived: sum of 2 quarters · filed 2026-08-17 | 0.00 shares 10-Q · filed 2025-11-10 | 228.47K shares derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | 0.00 shares 10-Q · filed 2026-08-17 | 228.47K shares derived: sum of 3 quarters · filed 2026-08-17 | 228.47K shares derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-11 | 228.47K shares derived: sum of 2 quarters · filed 2026-05-11 | 228.47K shares derived: sum of 3 quarters · filed 2026-05-11 | 456.82K shares derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | 228.47K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 228.47K shares derived: sum of 2 quarters · filed 2026-03-16 | 456.82K shares derived: sum of 3 quarters · filed 2026-03-16 | 506.82K shares 10-K · filed 2026-03-16 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 228.35K shares derived: sum of 2 quarters · filed 2024-11-07 | 278.35K shares 10-Q · filed 2024-11-07 | 728.49K shares derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | 228.35K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 278.35K shares 10-Q · filed 2024-08-07 | 728.49K shares derived: sum of 3 quarters · filed 2026-03-16 | 1.53M shares derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | 50.00K shares 10-Q · filed 2024-05-08 | 500.14K shares derived: sum of 2 quarters · filed 2026-03-16 | 1.30M shares derived: sum of 3 quarters · filed 2026-03-16 | |
| 2023-12-31 | 450.14K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 1.25M shares derived: sum of 2 quarters · filed 2026-03-16 | 1.57M shares 10-K · filed 2026-03-16 | |
| 2023-09-30 | 803.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | 1.12M shares 10-Q · filed 2023-11-06 | ||
| 2023-06-30 | 312.73K shares 10-Q · filed 2023-08-08 | |||
| 2022-12-31 | 3.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 3.42M shares derived: sum of 2 quarters · filed 2024-02-28 | 4.79M shares derived: sum of 3 quarters · filed 2024-02-28 | 5.44M shares 10-K · filed 2024-02-28 |
| 2022-09-30 | 154.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 1.53M shares derived: sum of 2 quarters · filed 2022-11-08 | 2.18M shares 10-Q · filed 2022-11-08 | |
| 2022-06-30 | 1.38M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 2.03M shares 10-Q · filed 2022-08-09 | ||
| 2022-03-31 | 650.12K shares 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | 5.50M shares 10-K · filed 2023-03-14 | |||
| 2020-12-31 | 1.04M shares 10-K · filed 2022-03-15 | |||
| 2019-12-31 | 1.32M shares 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |